Brief: Strides Pharma Science And Orbicular Enter Into A Strategic Partnership To Jointly Develop Nasal Sprays
May 3 (Reuters) - Strides Pharma Science Ltd SRID.NS :
* STRIDES AND ORBICULAR ENTER INTO A STRATEGIC PARTNERSHIP
TO
JOINTLY DEVELOP A RANGE OF NASAL SPRAYS
* PARTNERSHIP TO DEVELOP, MANUFACTURE AND COMMERCIALIZE
NASAL
SPRAYS FOR GLOBAL MARKETS
* PRODUCTS WILL BE MANUFACTURED AT COMPANY'S CHESTNUT RIDGE,
NEW
YORK FACILITY
Source text for Eikon: ID:nNSE7RhQpw
Further company coverage: SRID.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Strides Pharma Science
See all newsIndia's Strides Pharma jumps on successful closure of USFDA inspection at Bengaluru facility
Brief: Strides Pharma Science Receives USFDA EIR For Flagship Facility In Bengaluru
Brief: Strides Pharma Science Receives US FDA Establishment Inspection Report For Bengaluru Facility
Brief: Strides Pharma Science June-Quarter Consol Net Profit 1.57 Billion Rupees
Brief: Strides Pharma Science March-Quarter Consol Net Profit 1.27 Billion Rupees